Selenium Tetrabromide

Selenium tetrabromide (SeBr4) is an inorganic selenium halide compound with no documented therapeutic or nutritional applications. Unlike bioavailable selenium forms such as selenomethionine or sodium selenite, SeBr4 is classified as an acutely toxic industrial chemical with no evidence of safe human use.

Origin & History

Selenium tetrabromide (SeBr₄) is a synthetic inorganic compound produced by reacting elemental selenium with bromine gas, forming reddish-black crystals. It is a highly reactive chemical that decomposes in water or moist air to form selenous acid, with no natural biological origin or extraction method.

Historical & Cultural Context

Selenium tetrabromide has no historical use in any traditional medicine systems including Ayurveda or Traditional Chinese Medicine. As a synthetic compound with no stability in biological systems, it has never been employed for medicinal purposes.

Health Benefits

• No documented health benefits - highly toxic compound (H301, H311, H331)
• No clinical trials or biomedical applications found in literature
• Causes severe skin burns and eye damage (H314)
• Suspected carcinogen (H351) with specific target organ toxicity
• No evidence of therapeutic use due to extreme reactivity and toxicity

How It Works

Selenium tetrabromide hydrolyzes readily in aqueous environments to release hydrobromic acid (HBr) and selenium dioxide (SeO2), both of which are cytotoxic to biological tissues. The released SeO2 can oxidize thiol groups in proteins and disrupt glutathione peroxidase function, causing oxidative cellular damage rather than the antioxidant benefit associated with organic selenium species. Concurrent bromide ion release contributes to cellular toxicity by disrupting ionic homeostasis and halogenating biomolecules.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses exist for selenium tetrabromide. PubMed searches yield no PMIDs for biomedical studies, as this compound has never been investigated for therapeutic purposes due to its inherent toxicity and chemical instability.

Clinical Summary

No clinical trials, human studies, or controlled animal studies evaluating therapeutic use of selenium tetrabromide exist in the published biomedical literature as of 2024. The compound appears exclusively in industrial chemistry and toxicology contexts, with no PubMed-indexed trials or case reports of intentional therapeutic administration. Its GHS hazard classifications (H301, H311, H331, H314, H351) indicate acute oral, dermal, and inhalation toxicity as well as suspected carcinogenicity, making clinical investigation ethically unjustifiable. Evidence strength for any health application is rated as absent.

Nutritional Profile

Selenium Tetrabromide (SeBr4) is an inorganic halide compound with a molecular weight of 398.58 g/mol, consisting of approximately 19.8% selenium by mass and 80.2% bromine by mass. It is not a food ingredient, nutrient, or dietary supplement and has zero nutritional value. As a purely synthetic inorganic compound, it contains no macronutrients (zero protein, zero carbohydrates, zero fats, zero fiber), no vitamins, and no beneficial bioactive compounds. While selenium as an element is an essential micronutrient required by humans at trace levels (RDA: 55 mcg/day for adults), the selenium in SeBr4 is bound in a highly reactive, acutely toxic oxidation state (+4) that confers no nutritional bioavailability whatsoever. Bromine content similarly offers no nutritional benefit. The compound is highly reactive with moisture, hydrolyzing to form hydrobromic acid (HBr) and selenium oxybromide species, making any concept of 'bioavailability' relevant only in the context of toxic exposure pathways. No caloric value, no essential fatty acids, no antioxidant capacity, and no fiber content are present. This compound exists solely as an industrial/laboratory chemical and must not be considered in any nutritional context.

Preparation & Dosage

No clinically studied dosages exist as selenium tetrabromide has no biomedical applications. Occupational exposure limits are set at TWA 0.2 mg/m³ (ACGIH, NIOSH) for industrial settings only. This compound should never be used as a supplement. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

None - this compound should not be combined with any supplements

Safety & Interactions

Selenium tetrabromide is acutely toxic via oral ingestion, skin contact, and inhalation, with LD50 values in animal models consistent with severe systemic toxicity at low doses. It causes irreversible skin burns and serious eye damage (H314) due to rapid hydrolysis producing corrosive HBr and SeO2. The compound is a suspected carcinogen (H351) and carries specific target organ toxicity warnings for repeated exposure. It is absolutely contraindicated for human consumption, has no established safe dosage, and poses extreme risk during pregnancy and for all other populations.